Decibel Cannabis Company (TSE:DB)
:DB
Want to see TSE:DB full AI Analyst Report?
Top Page
Decibel Cannabis Company
(DB)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.11
▲(12.00% Upside)
Action:Reiterated
Date:06/13/26
The score is primarily held back by weakened cash generation (negative operating and free cash flow) and continued net losses despite improving revenue and EBITDA. Technical indicators also lean bearish with the price below key moving averages and a negative MACD, while valuation remains unattractive due to a negative P/E and no dividend yield support.
Positive Factors
Revenue and margin recovery
Sustained revenue growth with a return to positive EBITDA and improved gross margins indicates better product mix, pricing or cost control. If maintained, these operating improvements support durable cash generation potential and provide a firmer foundation for reinvestment and scaled profitability over the medium term.
Negative Factors
Deteriorated cash generation
A shift to negative operating and free cash flow is a structural concern: persistent cash outflows increase reliance on external financing, raise dilution or refinancing risk, and limit capacity to fund capex, inventory or marketing. Without sustained OCF recovery, growth and financial stability are constrained.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and margin recovery
Sustained revenue growth with a return to positive EBITDA and improved gross margins indicates better product mix, pricing or cost control. If maintained, these operating improvements support durable cash generation potential and provide a firmer foundation for reinvestment and scaled profitability over the medium term.
Read all positive factors
Decibel Cannabis Company (DB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$69.23M
Dividend YieldN/A
Average Volume (3M)258.21K
Price to Earnings (P/E)―
Beta (1Y)0.26
Revenue Growth30.71%
EPS Growth-123.40%
CountryCA
Employees171
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding576,900,000
10 Day Avg. Volume297,792
30 Day Avg. Volume258,209
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.02
Price to Sales (P/S)0.56
P/FCF Ratio11.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.27Price Target Upside166.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)<0.01
Revenue Forecast (FY)C$134.88M
Decibel Cannabis Company Business Overview & Revenue Model
Company Description
Decibel Cannabis Company Inc. operates within Canada's cannabis industry, overseeing the entire spectrum from growing and processing to manufacturing and selling its diverse product line. It serves other licensed Canadian producers by supplying ca...
How the Company Makes Money
Decibel Cannabis Company makes money primarily by selling finished cannabis products into Canada’s regulated legal market. Its core revenue streams generally include: (1) wholesale sales of branded cannabis products (e.g., dried flower and other f...
Decibel Cannabis Company Financial Statement Overview
Summary
Income Statement
49
Neutral
Balance Sheet
56
Neutral
Cash Flow
33
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 112.72M | 92.54M | 106.22M | 79.33M | 52.45M |
| Gross Profit | 17.49M | 37.58M | 38.77M | 26.43M | 28.17M |
| EBITDA | -10.80M | 21.53M | 3.25M | 2.26M | 9.45M |
| Net Income | -2.92M | 9.46M | -1.77M | -4.46M | 1.74M |
Balance Sheet | |||||
| Total Assets | 141.60M | 151.86M | 142.99M | 140.88M | 125.93M |
| Cash, Cash Equivalents and Short-Term Investments | 7.49M | 7.00M | 3.48M | 2.97M | 1.92M |
| Total Debt | 44.16M | 48.32M | 48.52M | 48.39M | 49.90M |
| Total Liabilities | 79.25M | 87.14M | 96.79M | 93.67M | 75.19M |
| Stockholders Equity | 62.35M | 64.72M | 46.20M | 47.21M | 50.73M |
Cash Flow | |||||
| Free Cash Flow | 5.47M | 3.21M | 4.92M | 4.44M | -20.39M |
| Operating Cash Flow | 7.46M | 3.98M | 7.08M | 8.26M | -17.15M |
| Investing Cash Flow | -1.98M | 1.19M | -2.13M | -3.76M | -3.23M |
| Financing Cash Flow | -4.98M | -1.65M | -4.43M | -3.45M | 18.47M |
Decibel Cannabis Company Technical Analysis
Positive
0.10
Price Trends
0.12
Negative
0.12
Positive
0.12
Positive
Market Momentum
>-0.01
Negative
50.87
Neutral
75.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DB, the sentiment is Positive. The current price of 0.1 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.12, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.87 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DB.
Decibel Cannabis Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | C$29.74M | -3.40 | -19.10% | ― | 0.66% | -14.29% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | C$60.79M | -0.61 | -112.30% | ― | -21.09% | -54.32% | |
45 Neutral | C$69.23M | -22.54 | 12.78% | ― | 30.71% | -123.40% | |
43 Neutral | C$68.69M | -2.46 | 169.17% | ― | ― | ― | |
41 Neutral | C$113.63M | -1.34 | -2065.45% | ― | -2.64% | -36.69% | |
41 Neutral | C$19.26M | -90.11 | -2.15% | ― | 24.10% | 94.52% |
* Healthcare Sector Average
TSE:DB
Decibel Cannabis Company
0.12
0.05
71.43%
TSE:LEEF
Leef Brands
0.25
0.04
16.67%
TSE:CWEB
Charlotte's Web Holdings
0.42
0.29
223.08%
TSE:LABS
MediPharm Labs
0.07
>-0.01
-6.67%
TSE:PLTH
Planet 13 Holdings
0.19
-0.07
-27.45%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.15
-0.05
-23.68%
Decibel Cannabis Company Corporate Events
Financial Disclosures
Decibel Cannabis to Release Q4 2025 Results on April 16, 2026
Neutral
Apr 8, 2026
Decibel Cannabis Company plans to release its fourth quarter 2025 financial results before markets open on April 16, 2026, and will hold a conference call later that morning to discuss its performance. The announcement signals an upcoming update o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.